|

Bacillus Calmette-Guerin: Strain TICE Clinical Trials

1 actively recruiting trial

Also known as: OncoTICE

Pipeline

Phase 3: 1

Top Sponsors

  • Verity Pharmaceuticals Inc.1

Indications

  • Non-Invasive Bladder Urothelial Carcinoma1
  • Neoplasm Recurrence1
  • Bladder Cancer Recurrent1
  • Urothelial Carcinoma Recurrent1
  • Urothelial Carcinoma Bladder1

Other1 trial

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.